Efficacy of lenvatinib plus pembrolizumab in hepatocellular carcinoma with metachronous lung metastasis: a report of two cases
CONCLUSIONS: The findings of the current study and recently published data indicate lung metastasis as a potential clinical therapeutic indicator for efficacy of immunotherapy against HCC.PMID:34296632 | DOI:10.1177/03008916211033353
Source: Tumori - Category: Cancer & Oncology Authors: JieLang Li Ting Chen Feng Bi Yu Yang Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | Study